127 countries are authorized but no China! The United States bought out 500,000 doses of”anti-epidemic magic drugs” and has now been investigated
Under the global lack of recognized anti-epidemic drugs, the Ridexivir developed by Gilead has gradually been accepted by many countries He has high hopes, even if it has not been fully proven to be effective. Previously, countries including South Korea, Japan, the United Kingdom and other countries have already provided forRed West,“green light“, Allow enterprises to introduce. According to reports from the British media, the European Union may also approve the use of ridxivir this week.
On the other hand, Gilead also actively explores the global market. According to previous reports, Gilead has reached an agreement with manufacturers in India, Egypt, Pakistan and other countries to allow them to supply redcive to 127 countries (excluding China), including countries with varying degrees of economic development. What many countries did not expect was that the United States started first, and bought out 90%of the market in advance.ReidsivirSupply. This has also led to investigations by world organizations.
According to the latest report from the US media, the World Health Organization Health Emergency Program is implemented for the matter that the United States has bought out almost all of the stocks of Redcive in the next three months. Director Michael Ryan responded, he said that he was using all his power to sort out and sort out and verify this report. He pointed out that many people in the world suffered from the epidemic, hoping to ensure that everyone receives the necessary ambulance treatment.
It is understood that the cause of the incident is the high-profile”propaganda” of the United States. On June 29, the U.S. Department of Health and Human Services stated that it had booked 500,000 with Gileadreserved 500,000agent >Redcliffe,andThis occupies Gilead’s companythe next three months90%Capacity. The Minister of the Department, Alex Hazard, said at the time that we would guarantee that any American patient who needed Radecivir would get it, and the agreement was”great”. In this regard, British media reported that the United States did not reservefor the United Kingdom and EuropepurchaseRedsevellRights, the vast majority of countries in the world can only be bought in the fall of the fastest.
It may be expected to cause dissatisfaction in advance, and Gilead gave the relevant explanation when releasing the pricing:National Institute of Allergy and Infectious Diseases (NIAID) research results It has been shown that, if you use Ridexivir, the recovery time of patients is shortened by an average of 4 days. Taking the United States as an example, each patient who is discharged early will save about $12,000expenses, current drugspricingactual Lower than the value of the drug.
It is worth noting that the results of the clinical trials of ridxivir in China were not satisfactory. On April 29 this year, the Chinese expert group published the results of the antiviral clinical trial of redoxivir in the international medical authority”Lancet”. The results show that, compared to placebo,Redesivir in the treatment of critically ill patientsEffect Limited, alsonotobviousaccelerating the rate of decline in viral load; good security,Not foundAbsolutely related adverse drug reactions.
This is contrary to the results of clinical trials published in the United States. In this regard, the person in charge of the Chinese clinical trial of Ridesivir believes that the different research endpoints bring about differences in results. The US NIH has a loose end-point indicator and the Chinese research assessment is stricter. Many scientists even warned that people should be cautious about the results of rapid research conducted during the epidemic.